cetpinhibition.org

Genetics

Elderly men carrying a CETP mutation trend toward the lowest heart disease rates in a 7-year Honolulu Heart Program follow-up (J Lipid Res 2004)

Original title: A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly

J Lipid Res · · 6

Curb JD, Abbott RD, Rodriguez BL, Masaki K, Chen R, Sharp DS, Tall AR

Since the relationship between HDL-cholesterol (HDL-C) and coronary heart disease (CHD) incidence is less clear in the elderly than in middle age, and controversy remains over whether CETP deficiency and its associated HDL-C rise are protective or, via impaired reverse cholesterol transport, detrimental, this study followed 2340 men aged 71-93 in the Honolulu Heart Program for 7 years. Age-adjusted CHD incidence was significantly lower in men with high versus low HDL-C. After adjustment for age, hypertension, smoking, and total cholesterol, the relative risk of CHD for men with HDL-C 60 mg/dL or higher versus below 40 mg/dL was 0.6. Men carrying a CETP mutation had the lowest CHD rates of any group, though this difference did not reach statistical significance. The authors conclude HDL-C remains an important CHD risk factor in the elderly, and whether CETP mutation carriage offers additional protection warrants further investigation.

Read the paper (DOI)PubMed

Original abstract

High density lipoprotein cholesterol (HDL-C) levels are inversely associated with the incidence of coronary heart disease (CHD) in middle-aged individuals; in the elderly, the association is less clear. Genetic factors, including variations in the cholesteryl ester transfer protein (CETP) gene, play a role in determining HDL-C levels. Controversy remains about whether CETP deficiency and the resultant rise in HDL-C are antiatherogenic, or whether CETP has the opposite effect due to its role in reverse cholesterol transport. In a seven-year follow-up of 2340 men aged 71-93 in the Honolulu Heart Program, the age-adjusted CHD incidence rates were significantly lower in men with high versus low HDL-C levels. After adjustment for age, hypertension, smoking, and total cholesterol, the relative risk of CHD for those with HDL-C levels >or=60 mg/dl, compared with those with HDL-C levels <40 mg/dl, was 0.6. Men with a CETP mutation had the lowest rates of CHD, although this was not statistically significant. These data indicate that HDL-C remains an important risk factor for CHD in the elderly. Whether a CETP mutation offers additional protection against CHD warrants further investigation.

geneticsHDL biology

Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.